Aignostics

Aignostics develops AI-powered foundation models and computational pathology tools to support drug development and precision medicine. The company provides services for target and biomarker discovery, translational research, and digital diagnostics by analyzing multimodal biomedical data, including H&E-stained whole slide images. Their platform serves life sciences companies and academic researchers by profiling the tumor microenvironment and identifying drug targets.